Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

Manufacturing in dec at 7-month high, PMI shows
The manufacturing sector in December climbed to its highest level since May 2009, signalling a faster monthly improvement in the key economic activity, an HSBC survey said today.

Tharoor's Kerala party
Minister of State for External Affairs Shashi Tharoor’s controversial stay in Taj Mansingh hotel had a grand finale with an Iftaar party. Among Tharoor’s five Keralite Cabinet colleagues, only Minister of State for Agriculture KV Thomas turned up at the Iftaar, which was attended by VIPs, including Vice-President Hamid Ansari. The next morning, Tharoor reciprocated this with his presence at the appam and mutton stew house-warming party at the official residence of Thomas, who has moved out of Kerala House. This was followed by Tharoor attending a multi-course luncheon hosted by employees of Kerala House to celebrate Onam. Tharoor had earlier checked out of Kerala House complaining “lack of a gym.’’

News of the day

'No role for govt, regulator in media, entertainment'
Blaming excessive regulations for the media and entertainment industry’s acute financial crisis, Rupert Murdoch’s Indian venture Star Group today said the government and regulator had no role in the sector.
Business Opportunities

Cipla gets NPPA notice on overpricing drugs

The National Pharmaceutical Pricing Authority (NPPA) has sent a notice to Cipla for allegedly overcharging customers. The government arm has imposed a fine on the company for selling Ciprofloxacin and Doxycycline medicines at a higher price than the one stated by the government. - Reaction from double top - Cipla rises 4.3% - Sunny re-rating of pharma companies - Cipla shares jump on Pfizer talk - Cipla in talks with Pfizer, others for alliance - Pharma world discovers Bharat NPPA is an agency established to fix the prices of controlled bulk drugs. NPPA has asked the company to pay Rs 20.1 crore for Ciprofloxacin, this includes an amount of Rs 8.6 crore as interest charges, Cipla said in a statement to the Bombay Stock Exchange (BSE). Cipla said it has also been asked to pay Rs 1.1 lakh for Doxycycline. The period, for which these amounts pertain to, has not been specified in the demand notice, the company said. "These demands are contrary to the orders of the Supreme Court and the company has received legal advice that entire amounts demanded by the government are not tenable and sustainable," the company notification said. Shares of the company settled at Rs 351.50, down 1.99 per cent on the BSE today.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009